Serum protein fingerprint of patients with pancreatic cancer by SELDI technology

Chinese Journal of Cancer Research

Volumn 20, Issue 3, 2008, Pages 171-176

  Ma, Ning ^a   Ge, Chun Lin ^a   Luan, Feng Ming ^a   Yao, Dian Bo ^b   Hu, Chao Jun ^b   Li, Ning ^b   Liu, Yong Feng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Biological markers; Pancreatic cancer; Proteomic; SELDI

Indexed keywords

BIOLOGICAL MARKER; PLASMA PROTEIN;

ADULT; AGED; ARTICLE; BIOTECHNOLOGY; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN REGULATION; FEMALE; HUMAN; MAGNETISM; MALE; MOLECULAR WEIGHT; PANCREAS CANCER; PANCREAS DISEASE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION; VOLUNTEER;

EID: 52949143800     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/S11670-008-0171-4     Document Type: Article

References (35)

1. Wray CJ, Ahmad SA, Matthews JB, et al. Surgery for pancreatic cancer: recent controversies and current practice [J]. Gastroenterology 2005; 128: 1626-41.
2. Li D, Xie K, Wolff R, et al. Pancreatic cancer [J]. Lancet 2004; 363:1049-57.
3. Hawes RH, Xiong Q, Waxman I, et al. A multispecialty approach to the diagnosis and management of pancreatic cancer [J]. Am J Gastroenterol 2000; 95:17-31.
4. Ishikawa O, Ohigashi H, Imaoka S, et al. Minute carcinoma of the pancreas measuring 1 cm or less in diameter - collective review of Japanese case reports [J]. Hepatogastroenterology 1999; 46:8-15.
5. Kalra MK, Maher MM, Mueller PR, et al. State-of-the-art imaging of pancreatic neoplasms [J]. Br J Radiol 2003; 76:857-65.
6. Carpelan-Holmström M, Louhimo J, Stenman UH, et al. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers [J]. Anticancer Res 2002; 22:2311-6.
7. Zhao XY, Yu SY, Da SP, et al. A clinical evaluation of serological diagnosis for pancreatic cancer [J]. World J Gastroenterol 1998; 4:147-9.
8. Kim JE, Lee KT, Lee JK, et al. Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population [J]. J Gastroenterol Hepatol 2004; 19:182-6.
9. Liotta LA, Kohn EC. The microenvironment of the tumor-host interfacen [J]. Nature 2001; 411:375-9.
10. Hanash SM. Global profiling of gene expression in cancer using genomics and proteomics [J]. Curr Opin Mol Ther 2001; 3:538-45.
11. Liotta LA, Ferrari M, Petricoin E. Clinical proteomics: written in blood [J]. Nature 2003; 425:905.
12. Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry [J]. Electrophoresis 2000; 21:1164-77.
13. Zhu H, Snyder M. Protein chip technology. Curr Opin Chem Biol 2003; 7:55-63.
14. Issaq HJ, Veenstra TD, Conrads TP, et al. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification [J]. Biochem Biophys Res Commun 2002; 292:587-92.
15. Rodland KD. Proteomics and cancer diagnosis: the potential of mass spectrometry [J]. Clin Biochem 2004; 37:579-83.
16. Conrads TP, Hood BL, Issaq HJ, et al. Proteomic patterns as a diagnostic tool for early-stage cancer: a review of its progress to a clinically relevant tool [J]. Mol Diagn 2004; 8:77-85.
17. Petricoin EF, Liotta LA. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer [J]. Cuff Opin Biotechnol 2004; 15:24-30.
18. Petricoin EF 3rd, Ornstein DK, Paweletz CP, et al. Serum proteomic patterns for detection of prostate cancer [J]. J Natl Cancer Inst 2002; 94:1576-8.
19. Bañez LL, Prasanna P, Sun L, et al. Diagnostic potential of serum proteomic patterns in prostate cancer [J]. J Urol 2003; 170:442-6.
20. Malik G, Ward MD, Gupta SK, et al. Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer [J]. Clin Cancer Res 2005; 11:1073-85.
21. Somiari RI, Somiari S, Russell S, et al. Proteomics of breast carcinoma [J]. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 815:215-25.
22. Langbein S, Lehmann J, Harder A, et al. Protein profiling of bladder cancer using the 2D-PAGE and SELDI-TOF-MS technique [J]. Technol Cancer Res Treat 2006; 5:67-72.
23. Paradis V, Degos F, Dargèe D, et al. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases [J]. Hepatology 2005; 41:40-7.
24. Kozak KR, Amneus MW, Pusey SM, et al. Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis [J]. Proc Natl Acad Sci USA 2003; 100:12343-8.
25. Adam BL, Qu Y, Davis JW, et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men [J]. Cancer Res 2002; 62:3609-14.
26. Issaq HJ. The role of separation science in proteomics research [J]. Electrophoresis 2001, 22:3629-38.
27. Kim JE, Lee KT, Lee JK, et al. Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population [J]. J Gastroenterol Hepatol 2004; 19:182-6.
28. Srinivas PR, Verma M, Zhao Y, et al. Proteomics for cancer biomarker discovery [J]. Clin Chem 2002; 48:1160-9.
29. Hanash S. Disease proteomics [J]. Nature 2003; 422:226-32.
30. Rosty C, Goggins M. Identification of differentially expressed proteins in pancreatic cancer using a global proteomic approach [J]. Methods Mol Med 2005; 103:189-97.
31. Bhattacharyya S, Siegel ER, Petersen GM, et al. Diagnosis of pancreatic cancer using serum proteomic profiling [J]. Neoplasia 2004; 6:674-86.
32. Koopmann J, Zhang Z, White N, et al. Serum diagnosis of pancreatic adenocarcinoma using surf ace-enhanced laser desorption and ionization mass spectrometry [J]. Clin Cancer Res 2004; 10:860-8.
33. Yun Y, Chen S, Wang LS, et al. Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser des orption/ionization-based decision tree classification [J]. Oncology 2005; 68:79-86.
34. Honda K, Hayashida Y, Umaki T, et al. Possible detection of pancreatic cancer by plasma protein profiling [J]. Cancer Res 2005; 65:10613-22.
35. Ehmann M, Felix K, Hartmann D, et al. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling [J]. Pancreas 2007; 34:205-14.